About this Presentation
Modern menopausal hormonal therapy used in women within 10 years of menopause is safe and effective and, in addition to symptom relief, has both bone and cardiovascular benefits. The small risks of breast cancer or uterine cancer may be reduced by using the lowest effective dose of body-identical oestrogen and progestogen. Transdermal oestrogen further decreases thromboembolic risks.
About the Expert
Prof Rod Baber
Rod Baber is Professor of Obstetrics and Gynaecology at The University of Sydney and operates a specialist Gynaecology and Reproductive Endocrinology practice based on Sydney's lower north shore. He also heads the menopause and menstrual disorders clinic at Royal North Shore Hospital. Rod is a life member and Past President Australasian menopause Society as well as Past President International Menopause Society where he is also Honorary Life Member. Rod is Editor-in-Chief of Climacteric, the journal of The International Menopause Society and is Associate Editor of ANZ Journal of Obstetrics and Gynaecology.
